Satellos Bioscience Inc. Research and Development Expense
Satellos Bioscience Inc. (MSLE) reported Research and Development Expense of $18.43 million for the 12-month period ending 2025-12-31, per its 40-F filed 2026-03-27.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:ResearchAndDevelopmentExpense · last filed 2026-03-27
CAD
| Period end | Research And Development Expense 12 month |
|---|---|
| 2024-12-31 | 19.60M CAD 40-F · filed 2026-03-27 |
USD
| Period end | Research And Development Expense 12 month |
|---|---|
| 2025-12-31 | $18.43M 40-F · filed 2026-03-27 |
| 2024-12-31 | $14.36M 40-F · filed 2026-03-27 |